NCT04093050View on ClinicalTrials.gov

Safety and Pharmacokinetics of Vasopressin in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

October 10, 2019

Primary Completion Date

April 8, 2021

Study Completion Date

April 11, 2021

Conditions
Healthy Volunteer Safety Study
Interventions
DRUG

Vasostrict Injectable Product

Vasostrict® (vasopressin injection, USP)

Trial Locations (2)

32806

Endo Clinical Trial Site #2, Orlando

78744

Endo Clinical Trial Site #1, Austin

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY